Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1999 May 4;18(9):2449-58.
doi: 10.1093/emboj/18.9.2449.

The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth

A Brehm  1 , S J Nielsen, E A Miska, D J McCance, J L Reid, A J Bannister, T Kouzarides
Affiliations

The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth

A Brehm et al. EMBO J. .

Abstract

E7 is the main transforming protein of human papilloma virus type 16 (HPV16) which is implicated in the formation of cervical cancer. The transforming activity of E7 has been attributed to its interaction with the retinoblastoma (Rb) tumour suppressor. However, Rb binding is not sufficient for transformation by E7. Mutations within a zinc finger domain, which is dispensable for Rb binding, also abolish E7 transformation functions. Here we show that HPV16 E7 associates with histone deacetylase in vitro and in vivo, via its zinc finger domain. Using a genetic screen, we identify Mi2beta, a component of the recently identified NURD histone deacetylase complex, as a protein that binds directly to the E7 zinc finger. A zinc finger point mutant which is unable to bind Mi2beta and histone deacetylase but is still able to bind Rb fails to overcome cell cycle arrest in osteosarcoma cells. Our results suggest that the binding to a histone deacetylase complex is an important parameter for the growthpromoting activity of the human papilloma virus E7 protein. This provides the first indication that viral oncoproteins control cell proliferation by targeting deacetylation pathways.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Nature. 1998 Feb 5;391(6667):597-601 - PubMed
    1. Int J Cancer. 1997 Aug 22;74(4):459-63 - PubMed
    1. J Virol. 1989 Jun;63(6):2650-6 - PubMed
    1. EMBO J. 1989 Dec 1;8(12):3905-10 - PubMed
    1. EMBO J. 1989 Dec 20;8(13):4099-105 - PubMed

Publication types

MeSH terms

LinkOut - more resources